EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The complement system and kidney cancer: pathogenesis to clinical applications

Ravikumar Aalinkeel, Richard J Quigg, Jessy Alexander

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci188351 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Ravikumar Aalinkeel und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: Complement System Proteins, Kidney Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney cancer poses unique clinical challenges because of its resistance to conventional treatments and its tendency to metastasize. The kidney is particularly susceptible to dysfunction of the complement system, an immune network that tumors often exploit. Recent discoveries have highlighted that the complement system not only plays a crucial role in immune surveillance and defense in the circulatory system, but also functions intracellularly and autonomously. This concept has shifted the focus of investigation toward understanding how complement proteins influence cancer progression by regulating the tumor microenvironment (TME), cell signaling, proliferation, metabolism, and the immune response. With the complement system and its inhibitors emerging as a promising new class of immunotherapeutics and potential complement-targeted treatments advancing through development pipelines and clinical trials, this Review provides a timely examination of how harnessing the complement system could lead to effective tumor treatments and how to strategically combine complement inhibitors with other cancer treatments, offering renewed hope in the fight against kidney cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement System ProteinsKidney NeoplasmsTumor MicroenvironmentHumansAnimalsComplement ActivationImmunotherapyComplement Inactivating Agents

Substanzen

Complement System ProteinsComplement Inactivating Agents

Zitieren

APA

Aalinkeel, R., Quigg, R. J., & Alexander, J. (2025). The complement system and kidney cancer: pathogenesis to clinical applications. Journal of Clinical Investigation. https://doi.org/10.1172/jci188351

Vancouver

Aalinkeel R, Quigg RJ, Alexander J. The complement system and kidney cancer: pathogenesis to clinical applications. Journal of Clinical Investigation. 2025. doi:10.1172/jci188351

BibTeX
@article{Aalinkeel2025,
  author = {Aalinkeel, Ravikumar and Quigg, Richard J and Alexander, Jessy},
  title = {The complement system and kidney cancer: pathogenesis to clinical applications},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci188351}
}
Kostenlos starten →